Preclinical Drug Discovery CRO

About ReproCELL

ReproCELL is a UK-based, privately-held life sciences company founded in 2003, operating at the intersection of stem cell technology, drug discovery, and precision medicine. It has evolved from a stem cell product supplier into an integrated global provider of research tools, GMP-compliant cell manufacturing, and human tissue-based preclinical contract research services. The company leverages strategic acquisitions to build a diversified portfolio that supports the entire drug development pipeline, from discovery through to clinical-stage cell therapy manufacturing. Its focus on human-derived models and regulatory-compliant services positions it as a key enabler for translational research.

Therapeutic Areas